AVBT — Avisa Diagnostics Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Avisa Diagnostics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2016 December 31st | 2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | fx Final | fx Final | Final | Final | Final |
Net Income/Starting Line | -0.089 | -0.043 | -6.5 | -4.13 | -0.716 |
Depreciation | |||||
Non-Cash Items | 0 | 0.018 | 3.25 | 1.66 | 0.031 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.035 | -0.006 | 0.065 | 0.16 | 0.212 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -0.055 | -0.031 | -1.98 | -1.35 | -0.452 |
Capital Expenditures | — | — | -0.021 | -0.028 | 0 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | — | — | -0.233 | 0 | — |
Acquisition of Business | |||||
Change in Net Intangibles | |||||
Cash from Investing Activities | — | — | -0.254 | -0.028 | 0 |
Financing Cash Flow Items | — | — | 0.001 | 0 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.055 | 0.048 | 3.68 | 0 | 0.144 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0 | 0.017 | 1.45 | -1.38 | -0.316 |